培哚普利与贝那普利治疗心力衰竭疗效比较
|
摘要
目的研究培哚普利与贝那普利治疗心力衰竭的临床疗效。方法选取2015年2—11月在我院接受治疗的114例心力衰竭患者,随机分组为观察组和对照组,各57例,对照组患者采用培哚普利治疗,观察组患者采用贝那普利治疗。对两组患者进行药物治疗后的有效率和不良反应结果进行分析比较。结果观察组患者的有效率与对照组患者结果相近,差异无统计学意义(P>0.05),两组患者的不良反应差异无统计学意义(P>0.05)。结论两组患者在接受培哚普利和贝那普利治疗后可以观察到两种药物的治疗效果作用相近,并无太大差别。
Objective To study the clinical efficacy of perindopril and bnazepril in the treatment of heart failure.Methods 114 patients with heart failure treated in our hospital for February to December 2015 were randomly divided into two groups: the observation group and the control group,with 57 cases in each group.The control group was treated with perindopril,and the observation group was treated with perindopril.The efficacy and adverse effects of two groups of patients were analyzed and compared.Results The effective rate of the patients in the observation group was similar to that of the control group.The difference was not statistically significant(P > 0.05),and there was no significant difference in the adverse reactions between the two groups,and there was no significant difference(P > 0.05).Conclusion In the two groups of patients receiving perindopril and bnazepril treatment,it is obvious that the effect of the two drugs is similar,and there is no big difference.
Objective To study the clinical efficacy of perindopril and bnazepril in the treatment of heart failure.Methods 114 patients with heart failure treated in our hospital for February to December 2015 were randomly divided into two groups: the observation group and the control group,with 57 cases in each group.The control group was treated with perindopril,and the observation group was treated with perindopril.The efficacy and adverse effects of two groups of patients were analyzed and compared.Results The effective rate of the patients in the observation group was similar to that of the control group.The difference was not statistically significant(P > 0.05),and there was no significant difference in the adverse reactions between the two groups,and there was no significant difference(P > 0.05).Conclusion In the two groups of patients receiving perindopril and bnazepril treatment,it is obvious that the effect of the two drugs is similar,and there is no big difference.
引文
[1]詹军娜.用贝那普利治疗慢性心力衰竭的效果观察[J].当代医药论丛,2016,14(18):101-102.
[2]黄震华,顾燕,许左隽.培哚普利与贝那普利治疗左心心力衰竭的比较[J].中国新药与临床杂志,2000,19(4):244-246.
[3]顾永伟.贝那普利治疗慢性心力衰竭患者临床效果观察[J].临床合理用药杂志,2017,10(23):29-30.
[4]郭凯,赵凤林,陈彬勇,等.贝那普利治疗心力衰竭的效果探析[J].当代医药论丛,2017,15(2):32-33.
[5]王九田.美托洛尔联合贝那普利治疗慢性心力衰竭临床疗效分析[J].基层医学论坛,2016,20(11):1592-1593.
[6]谢峰.不同剂量贝那普利治疗慢性充血性心力衰竭临床效果对比分析[J].基层医学论坛,2016,20(32):4550-4551.
[7]季真祥.慢性心衰采用美托洛尔联合贝那普利治疗的临床疗效分析[J].中外医疗,2016,35(30):139-141.
[8]朱玉江,邢晓龙,王西辉.托拉塞米联合培哚普利治疗心力衰竭的临床研究[J].现代药物与临床,2017,32(9):1631-1634.
[9]邓美芳,胡燕.心理干预联合缬沙坦、贝那普利治疗充血性心力衰竭的临床研究[J].中国生化药物杂志,2017,37(8):161-162.
[10]付美英.浅析我院抗高血压药的临床应用情况[J].当代医药论丛,2017,15(1):30-31.
[11]刘宇,张程亮,刘东.2012—2014年武汉市32家医院血管紧张素转换酶抑制剂应用分析[J].中国医院用药评价与分析,2016,16(7):962-964.
[12]王健蓉,袁君.氨氯地平对心衰合并高血压患者左心室功能的影响[J].西北国防医学杂志,2011,32(6):456-457.
[2]黄震华,顾燕,许左隽.培哚普利与贝那普利治疗左心心力衰竭的比较[J].中国新药与临床杂志,2000,19(4):244-246.
[3]顾永伟.贝那普利治疗慢性心力衰竭患者临床效果观察[J].临床合理用药杂志,2017,10(23):29-30.
[4]郭凯,赵凤林,陈彬勇,等.贝那普利治疗心力衰竭的效果探析[J].当代医药论丛,2017,15(2):32-33.
[5]王九田.美托洛尔联合贝那普利治疗慢性心力衰竭临床疗效分析[J].基层医学论坛,2016,20(11):1592-1593.
[6]谢峰.不同剂量贝那普利治疗慢性充血性心力衰竭临床效果对比分析[J].基层医学论坛,2016,20(32):4550-4551.
[7]季真祥.慢性心衰采用美托洛尔联合贝那普利治疗的临床疗效分析[J].中外医疗,2016,35(30):139-141.
[8]朱玉江,邢晓龙,王西辉.托拉塞米联合培哚普利治疗心力衰竭的临床研究[J].现代药物与临床,2017,32(9):1631-1634.
[9]邓美芳,胡燕.心理干预联合缬沙坦、贝那普利治疗充血性心力衰竭的临床研究[J].中国生化药物杂志,2017,37(8):161-162.
[10]付美英.浅析我院抗高血压药的临床应用情况[J].当代医药论丛,2017,15(1):30-31.
[11]刘宇,张程亮,刘东.2012—2014年武汉市32家医院血管紧张素转换酶抑制剂应用分析[J].中国医院用药评价与分析,2016,16(7):962-964.
[12]王健蓉,袁君.氨氯地平对心衰合并高血压患者左心室功能的影响[J].西北国防医学杂志,2011,32(6):456-457.